Inventor · disambiguated record
John P. Fischer
Also filed as: FISCHER JOHN · FISCHER JOHN P · FISCHER JOHN PETER
24 granted patents·18 pending applications·338 citations·filing 2002–2025
95Inventor score
Files withMIRATI THERAPEUTICS INC16ARRAY BIOPHARMA INC11COGENT BIOSCIENCES INC6AICHER THOMAS DANIEL4ROCHE PALO ALTO LLC2
Top patents by PatentIndex Score
42 records- 0197US10689377B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Jun 23, 2020·16 cites·57 claims
- 0297US6831175B2Kinase inhibitorsABBOTT LAB·Filed 2002·Granted Dec 14, 2004·214 cites·21 claims
- 0396US11453683B1KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Sep 27, 2022·13 cites·84 claims
- 0496US10125134B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Nov 13, 2018·43 cites·9 claims
- 0593US10633381B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·8 cites·7 claims
- 0692US11964989B2KRas G12D inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·2 cites·19 claims
- 0791US11267812B2KRAS G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·11 cites·34 claims
- 0889US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 0989US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 1089US7674810B21,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymeraseROCHE PALO ALTO LLC·Filed 2006·Granted Mar 9, 2010·8 cites·15 claims
- 1187US7479489B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2005·Granted Jan 20, 2009·7 cites·41 claims
- 1282US11548888B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2020·Granted Jan 10, 2023·1 cites·9 claims
- 1382US2024101553A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1481US11932633B2KRas G12C inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Granted Mar 19, 2024·2 cites·41 claims
- 1581US8212045B2Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2008·Granted Jul 3, 2012·4 cites·9 claims
- 1679US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1778US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 1878US2023373999A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1977US2024309020A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2076US2025066357A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2174US11884664B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2022·Granted Jan 30, 2024·0 cites·16 claims
- 2269US8853409B2Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2012·Granted Oct 7, 2014·1 cites·32 claims
- 2368US12351581B2Compounds for FGFR inhibitionCOGENT BIOSCIENCES INC·Filed 2024·Granted Jul 8, 2025·0 cites·30 claims
- 2467US12281122B1PI3K inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 2564US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 2663US12187721B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
- 2760US9079890B2Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Jul 14, 2015·0 cites·12 claims
- 2858US2025270211A1Compounds for fgfr inhibitionCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2957US2024034733A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3056US2024270741A1Compounds for fgfrs inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3155US2023357277A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3254US2023339976A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3353US2025129078A1Erbb2 inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 3453US2023279025A1Kras g12d inhibitorsMIRATI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3548US2025206752A1Pi3k inhibitorsCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3647US2021230170A1Kras g12c inhibitorsMIRATI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3746US2003187026A1Kinase inhibitorsFiled 2002·Application pending·0 cites
- 3842US2014309226A1Piperidinyl-substituted cyclic ureas as gpr119 modulatorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 3941US2014256756A1Piperidinyl-substituted lactams as gpr119 modulatorsARRAY BIOPHARMA INC·Filed 2012·Application pending·0 cites
- 4038US2013184257A1Piperidinyl-substituted lactams as gpr119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Application pending·0 cites
- 4137US8754226B2Piperidinyl-substituted lactams as GPR119 modulatorsAICHER THOMAS DANIEL·Filed 2011·Granted Jun 17, 2014·0 cites·71 claims
- 4236US8865726B2Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsANDREWS STEVEN W·Filed 2010·Granted Oct 21, 2014·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when John P. Fischer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →